United States Point-of-care Molecular Diagnostic Solution Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 3.3 Billion by 2030, growing at a CAGR of 11.6% from 2024 to 2030.
The US Point-of-care Molecular Diagnostic Solution Market is experiencing significant growth, driven by the increasing demand for quick and accurate diagnostic tools. With the advancement of molecular diagnostic technologies, healthcare providers now have access to solutions that can deliver rapid results, offering a key advantage in emergency situations and ongoing patient care. As the need for early disease detection and faster treatment decisions rises, industries, particularly healthcare, are increasingly looking toward molecular diagnostics at the point of care.
Point-of-care Molecular Diagnostic Solutions provide a revolutionary way to test for various infectious diseases, genetic conditions, and other health concerns without the need for traditional lab testing. These solutions are particularly beneficial in settings like hospitals, clinics, emergency rooms, and even at home care. For industries, these diagnostic solutions represent a game-changer, offering faster turnaround times, cost savings, and reduced strain on healthcare infrastructure.
One of the most critical aspects of the market’s growth is the widespread adoption of portable, easy-to-use devices that facilitate on-site testing. Industries, including healthcare, pharmaceutical, and research sectors, now have the ability to perform accurate molecular diagnostics directly at the patient’s side. This capability not only increases efficiency but also enhances patient outcomes through quicker decision-making processes. With real-time data, healthcare providers can initiate treatments immediately, reducing patient wait times and improving overall care delivery.
The demand for Point-of-care Molecular Diagnostic Solutions is also being fueled by the rising prevalence of chronic diseases, infectious outbreaks, and the ongoing shift towards personalized medicine. These solutions empower healthcare providers to detect conditions at an earlier stage, providing an opportunity for timely interventions and tailored treatments. As the technology improves, it is expected that the market will continue to expand, offering even more precise and diversified diagnostic capabilities to meet the growing needs of various industries.
Healthcare professionals and industries are particularly interested in the convenience and versatility these solutions offer. Moreover, the ongoing development of innovative testing kits, including those that can detect multiple pathogens at once, is expected to further drive market adoption. With a growing focus on improving patient care and operational efficiency, the US Point-of-care Molecular Diagnostic Solution Market is poised for significant growth in the coming years.
Get an In-Depth Research Analysis of the US Point-of-care Molecular Diagnostic Solution Market Size And Forecast [2025-2032]
Â
Abbott Laboratories
F. Hoffmann-La Roche AG
Becton
Dickinson and Company
BioMerieux
Bio-Rad Laboratories
Inc.
Cepheid
Inc.
Danaher Corporation
Johnson and Johnson
Bayer Healthcare
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Point-of-care Molecular Diagnostic Solution Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Point-of-care Molecular Diagnostic Solution Market
Polymerase Chain Reaction (PCR)
Isothermal Amplification
Next-Generation Sequencing (NGS)
Microarray
Instruments
Reagents & Consumables
Software & Services
Infectious Diseases
Cancer Diagnostics
Genetic Testing
Blood Screening
Hospitals
Diagnostic Laboratories
Research Institutes
Point-of-Care Settings
Blood
Urine
Saliva
Other Bodily Fluids
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Point-of-care Molecular Diagnostic Solution Market Research Analysis
1. Introduction of the US Point-of-care Molecular Diagnostic Solution Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Point-of-care Molecular Diagnostic Solution Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Point-of-care Molecular Diagnostic Solution Market, By Type
6. US Point-of-care Molecular Diagnostic Solution Market, By Application
7. US Point-of-care Molecular Diagnostic Solution Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Point-of-care Molecular Diagnostic Solution Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/